CYRX
Cryoport, Inc.
Key Financials
Gross Profit
$83.1M
↓ 16.6%
Operating Income
$-36806000
↑ 71.9%
Net Income
$78.3M
↑ 168.2%
Revenue
$176.2M
↓ 22.9%
EPS (Diluted)
$1.40
↑ 156.2%
Total Liabilities
$262.4M
↓ 13.0%
Total Assets
$765.0M
↑ 8.7%
Long-term Debt
$1.3M
↑ 297.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYRX |
| Company Name | Cryoport, Inc. |
| CIK | 1124524 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | (949) 232-1900 |